Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wang, Wen Juan ^a   Yao, Yu ^a   Jiang, Li Li ^a   Hu, Ting Hua ^a   Ma, Jie Qun ^a   Liao, Zi Jun ^b   Yao, Jun Tao ^b   Li, Dong Fan ^c   Wang, Shu Hong ^a   Nan, Ke Jun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c Xi'an Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1;

ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INFILTRATION; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL CYCLE; CELL VIABILITY; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEF1 GENE; LENTIVIRINAE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; LENTIVIRUS; LYMPHATIC METASTASIS; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION;

EID: 84884842132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076596     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300. doi:10.3322/caac.20073. PubMed: 20610543.
2. Gansler T, Ganz PA, Grant M, Greene FL, Johnstone P, et al. (2010) Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin 60: 345-350. doi:10.3322/caac.20088. PubMed: 21075954.
3. Lei T, Chen WQ, Zhang SW, Lei TH, Ying Q, et al. (2009) [Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002]. Zhonghua Zhong Liu Za Zhi 31: 428-433. PubMed: 19950551.
4. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, et al. (2013) Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 34: 803-811. doi:10.1093/carcin/bgs400. PubMed: 23275153.
5. Waterman ML, Fischer WH, Jones KA, (1991) A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev 5: 656-669. doi:10.1101/gad.5.4.656. PubMed: 2010090.
6. Travis A, Amsterdam A, Belanger C, Grosschedl R, (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 5: 880-894. doi:10.1101/gad.5.5.880. PubMed: 1827423.
7. Gao X, Wen J, Zhang L, Li X, Ning Y, et al. (2008) Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus. J Biol Chem 283: 35679-35688. doi:10.1074/jbc.M804088200. PubMed: 18936100.
8. Hoeppner LH, Secreto FJ, Razidlo DF, Whitney TJ, Westendorf JJ, (2011) Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. J Biol Chem 286: 10950-10959. doi:10.1074/jbc.M110.165100. PubMed: 21270130.
9. Shelton DN, Fornalik H, Neff T, Park SY, Bender D, et al. (2012) The role of LEF1 in endometrial gland formation and carcinogenesis. PLOS ONE 7: e40312. doi:10.1371/journal.pone.0040312. PubMed: 22792274.
10. Waterman ML, (2004) Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev 23: 41-52. doi:10.1023/A:1025858928620. PubMed: 15000148.
11. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26. doi:10.1016/j.devcel.2009.06.016. PubMed: 19619488.
12. Yokoyama NN, Pate KT, Sprowl S, Waterman ML, (2010) A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res 38: 6375-6388. doi:10.1093/nar/gkq492. PubMed: 20525792.
13. Li Y, Wang L, Zhang M, Melamed J, Liu X, et al. (2009) LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res 69: 3332-3338. doi:10.1158/0008-5472.CAN-08-3380. PubMed: 19351848.
14. Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton AW, et al. (2002) Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem 277: 45847-45853. doi:10.1074/jbc.M209354200. PubMed: 12235165.
15. Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, et al. (2007) PITX2 and beta-catenin interactions regulate Lef-1 isoform expression. Mol Cell Biol 27: 7560-7573. doi:10.1128/MCB.00315-07. PubMed: 17785445. doi:10.1128/MCB.00315-07 PubMed: 17785445.
16. Huang FI, Chen YL, Chang CN, Yuan RH, Jeng YM, (2012) Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. Carcinogenesis 33: 1142-1148. doi:10.1093/carcin/bgs131. PubMed: 22436613.
17. Guo H, Lv Y, Tian T, Hu TH, Wang WJ, et al. (2011) Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma. Carcinogenesis 32: 1897-1904. doi:10.1093/carcin/bgr220. PubMed: 22002319.
18. Fre S, Pallavi SK, Huyghe M, Laé M, Janssen KP, et al. (2009) Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci U S A 106: 6309-6314. doi:10.1073/pnas.0900427106. PubMed: 19251639.
19. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, et al. (2009) WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51-62. doi:10.1016/j.cell.2009.04.030. PubMed: 19576624.
20. Kriegl L, Horst D, Reiche JA, Engel J, Kirchner T, et al. (2010) LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J Transl Med 8: 123. doi:10.1186/1479-5876-8-123. PubMed: 21092222.
21. Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, et al. (2011) Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLOS ONE 6: e16636. doi:10.1371/journal.pone.0016636. PubMed: 21383983.
22. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, et al. (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96: 5522-5527. doi:10.1073/pnas.96.10.5522. PubMed: 10318916.
23. Wang SH, Nan KJ, Wang YC, Wang WJ, Tian T, (2012) The balance between two isoforms of LEF-1 regulates colon carcinoma growth. BMC Gastroenterol 12: 53. doi:10.1186/1471-230X-12-53. PubMed: 22639890.
24. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, et al. (2006) Circulating MMP2 and MMP9 in breast cancer-- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119: 1403-1411. doi:10.1002/ijc.21989. PubMed: 16615109.
25. Bourboulia D, Stetler-Stevenson WG, (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20: 161-168. doi:10.1016/j.semcancer.2010.05.002. PubMed: 20470890.
26. Bucan V, Mandel K, Bertram C, Lazaridis A, Reimers K, et al. (2012) LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells. Genes Cells 17: 559-567. doi:10.1111/j.1365-2443.2012.01613.x. PubMed: 22686279.
27. Miele L, (2006) Notch signaling. Clin Cancer Res 12: 1074-1079. doi:10.1158/1078-0432.CCR-05-2570. PubMed: 16489059.
28. Miele L, Miao H, Nickoloff BJ, (2006) NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets 6: 313-323. doi:10.2174/156800906777441771. PubMed: 16848722.
29. Pannequin J, Bonnans C, Delaunay N, Ryan J, Bourgaux JF, et al. (2009) The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells. Cancer Res 69: 6065-6073. doi:10.1158/0008-5472.SABCS-6065. PubMed: 19622776.
30. Espinosa L, Inglés-Esteve J, Aguilera C, Bigas A, (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278: 32227-32235. doi:10.1074/jbc.M304001200. PubMed: 12794074.
31. Estrach S, Ambler CA, Lo Celso C, Hozumi K, Watt FM, (2006) Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development 133: 4427-4438. doi:10.1242/dev.02644. PubMed: 17035290.
32. Ungerbäck J, Elander N, Grünberg J, Sigvardsson M, Söderkvist P, (2011) The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells. PLOS ONE 6: e17957. doi:10.1371/journal.pone.0017957. PubMed: 21437251.
33. Ross DA, Kadesch T, (2001) The notch intracellular domain can function as a coactivator for LEF-1. Mol Cell Biol 21: 7537-7544. doi:10.1128/MCB.21.22.7537-7544.2001. PubMed: 11604490.